Centaurus: inhibiting ceramide synthesis for cardiometabolic disease

Centaurus is aiming for first-in-class small molecules that block the lipotoxicity driving cardiometabolic diseases.

Stress stimuli such as inflammation increase production of the structural lipid ceramide, which induces apoptosis, necroptosis and cellular metabolism defects...